FDA approves subcutaneous isatuximab-irfc for multiple myeloma
Isatuximab-irfc is currently approved across three indications in the US, including in combination with bortezomib, lenalidomide and dexamethasone in patients with newly diagnosed
Multiple Myeloma
News
EHA 2026
ASCO 2026
Leukemia
Acute Lymphoblastic Leukemia
Chronic Myeloid Leukemia
Video Interviews
ASCO and EHA 2026 updates on the third-gen TKI olverembatinib
Dr. Jabbour details safety and efficacy findings for an olverembatinib plus blinatumomab combination in leukemia.
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
News
Global KMT2A MRD testing launched for AML,ALL
The standardized assay targets common KMT2A partner fusion genes to support disease characterization and longitudinal monitoring in menin inhibitor clinical trials.
Community Oncology News
Trending now
Leukemia
Acute Lymphoblastic Leukemia
Lymphoma
Aggressive B-Cell Lymphomas
Video Interviews
Dr. Gwen Nichols: Addressing funding gaps in blood cancer research
Host Dr. Loretta Nastoupil and guest Dr. Nichols discuss how to build academic partnerships, leverage Blood Cancer United's free nurse navigation and financial
Focus on CELMoDs
EHA 2026
Meetings / Conferences
Multiple Myeloma
Roundtable Discussions
Video Interviews
How to sequence mezigdomide-based therapy in myeloma?
In this multiple myeloma roundtable from EHA 2026, the roundtable panelists evaluate the strategic sequencing of mezigdomide-based therapy, its potential as a bridging
Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Aggressive B-Cell Lymphomas
Myeloproliferative Neoplasms
News
FDA approves rituximab biosimilar for B-cell malignancies
The United States Food and Drug Administration has approved a rituximab biosimilar candidate developed by pharmaceutical company Dr. Reddy's Laboratories.
EHA 2026
Leukemia
Acute Lymphoblastic Leukemia
Lymphoma
Aggressive B-Cell Lymphomas
Meetings / Conferences
Multiple Myeloma
Video Interviews
Doris Ponce, MD, discusses bone health findings with axatilimab in chronic GVHD
Dr. Ponce outlines bone health parameters for axatilimab, a high-affinity anti-CSF-1R monoclonal antibody.
Ambassador Program
News
2026 SOHO Brazil meeting attracts nearly 1,000 attendees
Held annually in São Paulo, SOHO Brazil is part of the SOHO Ambassador Program, which supports regional meetings around the world to expand
Multiple Myeloma
News
Clinical use assay launched for MRD detection in myeloma
The assay supports treatment evaluation and risk stratification by detecting residual disease or early reemergence that standard testing might miss.
EHA 2026
Meetings / Conferences
Myelodysplastic Syndromes
Video Interviews
Updated phase 2 trial results of elritercept in patients with LR-MDS
Dr. Campelo outlines safety and efficacy data for this novel TGF-beta pathway inhibitor, highlighting transfusion independence rates, overall response rates, and safety outcomes